UK Agency Tests Remote Inspections Program To Identify At-Risk GDP Sites
Executive Summary
The UK Medicines and Healthcare products Regulatory Agency is testing a new remote, office-based inspection process, in place of physical inspections, to assess risk at “satellite sites” that perform a limited number of good distribution practice-related activities for companies.